ACLARIS THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 21 Aug 2024)
What this means for you
This application is over — abandoned 08 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98161577
- Mark type
- Design + words
- Filed
- 01 Sept 2023
- Abandoned
- 08 Aug 2024
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: anti-inflammatories; pharmaceutical preparations for dermatological, gastro-intestinal, autoimmune, immune system, skin, oncological, immuno-inflammatory, musculoskeletal, respiratory, central nervous system, kidney diseases, cardiovascular, endocrine, tissue and organ, ocular, ophthalmological, metabolic, genitourinary, urological, hepatic, otolaryngology, hematologic, genetic, and bone diseases and disorders; pharmaceutical preparations for the treatment of transplant rejection, graft-versus-host disease, vasculitis, myositis, myopathies, diabetes, allergies, asthma, and hair loss
Owner
- Aclaris Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 21 Aug 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 21 Aug 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 07 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 May 2024 — NON-FINAL ACTION E-MAILED
- 07 May 2024 — NON-FINAL ACTION WRITTEN
- 30 Apr 2024 — ASSIGNED TO EXAMINER
- 02 Nov 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Nov 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Nov 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Sept 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 27 Sept 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Sept 2023 — NEW APPLICATION ENTERED